Position in DHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$128,383
+$593 QoQ
Shares Held
674
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,806
of 2,098 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $3,045,618 across 9 Diagnostics & Research names. DHR ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
3,741 | $1,047,480 | |
| 2 | DGX |
Quest Diagnostics Inc
|
4,707 | $997,648 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
1,110 | $587,844 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
452 | $226,614 | |
| 5 | DHR |
Danaher Corp /De/
This page
|
674 | $128,383 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
69 | $36,324 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
100 | $19,322 | |
| 8 | NTRA |
Natera, Inc.
|
6 | $1,628 |
All Filings in DHR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $128,383 | 674 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $127,790 | 674 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $154,292 | 674 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $133,141 | 674 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $146,165 | 713 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $163,669 | 713 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $274,683 | 988 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $246,851 | 988 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $246,723 | 988 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $228,563 | 988 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $245,122 | 988 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $237,120 | 988 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $256,324 | 1,017 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $269,932 | 1,017 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $262,680 | 1,017 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $257,829 | 1,017 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $217,650 | 742 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $244,125 | 742 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $253,902 | 834 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $215,493 | 803 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $162,732 | 723 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $160,607 | 723 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $209,085 | 971 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $166,573 | 942 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $138,825 | 1,003 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||